RVL Pharmaceuticals
RVLP
#10128
Rank
ยฃ2.49 M
Marketcap
ยฃ0.02243
Share price
-32.05%
Change (1 day)
-5.04%
Change (1 year)

Revenue for RVL Pharmaceuticals (RVLP)

Revenue in 2023 (TTM): ยฃ30.75 Million

According to RVL Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ29.37 Million. In 2022 the company made a revenue of ยฃ41.09 Million an increase over the revenue in the year 2021 that were of ยฃ29.96 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for RVL Pharmaceuticals from 2018 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ30.75 M-25.17%
2022 ยฃ41.09 M37.16%
2021 ยฃ29.96 M-77.04%
2020 ยฃ0.13 B-28.71%
2019 ยฃ0.18 B-11.89%
2018 ยฃ0.20 B